|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
20
|
|
pubmed:dateCreated |
2008-10-17
|
|
pubmed:abstractText |
Non-small cell lung carcinoma (NSCLC) is one of most common malignant diseases and usually is resistant against apoptosis-inducing chemotherapy. This study is to explore the antiapoptotic mechanisms of interleukin (IL)-22 in human lung cancer.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Caspases,
http://linkedlifedata.com/resource/pubmed/chemical/Interleukins,
http://linkedlifedata.com/resource/pubmed/chemical/Mitogen-Activated Protein Kinase 1,
http://linkedlifedata.com/resource/pubmed/chemical/Mitogen-Activated Protein Kinase 3,
http://linkedlifedata.com/resource/pubmed/chemical/RNA, Messenger,
http://linkedlifedata.com/resource/pubmed/chemical/RNA, Small Interfering,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Interleukin,
http://linkedlifedata.com/resource/pubmed/chemical/STAT3 Transcription Factor,
http://linkedlifedata.com/resource/pubmed/chemical/interleukin-22,
http://linkedlifedata.com/resource/pubmed/chemical/interleukin-22 receptor
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
1078-0432
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
15
|
|
pubmed:volume |
14
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
6432-9
|
|
pubmed:dateRevised |
2009-11-19
|
|
pubmed:meshHeading |
pubmed-meshheading:18927282-Adenocarcinoma,
pubmed-meshheading:18927282-Animals,
pubmed-meshheading:18927282-Apoptosis,
pubmed-meshheading:18927282-Blotting, Western,
pubmed-meshheading:18927282-Carcinoma, Non-Small-Cell Lung,
pubmed-meshheading:18927282-Carcinoma, Squamous Cell,
pubmed-meshheading:18927282-Case-Control Studies,
pubmed-meshheading:18927282-Caspases,
pubmed-meshheading:18927282-Cell Proliferation,
pubmed-meshheading:18927282-Humans,
pubmed-meshheading:18927282-Immunoenzyme Techniques,
pubmed-meshheading:18927282-Interleukins,
pubmed-meshheading:18927282-Lung,
pubmed-meshheading:18927282-Lung Neoplasms,
pubmed-meshheading:18927282-Male,
pubmed-meshheading:18927282-Mice,
pubmed-meshheading:18927282-Mice, Inbred BALB C,
pubmed-meshheading:18927282-Mice, Nude,
pubmed-meshheading:18927282-Mitogen-Activated Protein Kinase 1,
pubmed-meshheading:18927282-Mitogen-Activated Protein Kinase 3,
pubmed-meshheading:18927282-Pleural Effusion, Malignant,
pubmed-meshheading:18927282-RNA, Messenger,
pubmed-meshheading:18927282-RNA, Small Interfering,
pubmed-meshheading:18927282-Receptors, Interleukin,
pubmed-meshheading:18927282-Reverse Transcriptase Polymerase Chain Reaction,
pubmed-meshheading:18927282-STAT3 Transcription Factor,
pubmed-meshheading:18927282-Transplantation, Heterologous,
pubmed-meshheading:18927282-Tumor Cells, Cultured
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Antiapoptotic activity of autocrine interleukin-22 and therapeutic effects of interleukin-22-small interfering RNA on human lung cancer xenografts.
|
|
pubmed:affiliation |
Institute of Immunology, University of Science and Technology of China, Hefei, People's Republic of China.
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|
